Q3 2015 Holdings
Filed 2015-11-13 | 77 holdings | $325.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Shire PLC | SP ADR | 82481R106 | $25.1K | 122,056 | 0.0% |
| Dexcom Inc(DXCM) | COMMON | 252131107 | $27.8K | 323,233 | 0.0% |
| Teva Pharmaceutical(TEVA) | ADR | 881624209 | $33.6K | 594,950 | 0.0% |
| Medtronic PLC(MDT) | SHARES | G5960L103 | $35.2K | 525,952 | 0.0% |
| Halozyme Therapeutic(HALO) | COMMON | 40637H109 | $35.9K | 2,671,051 | 0.0% |
| Intercept Pharmaceuticals(ICPTUSD) | COMMON | 45845P108 | $36.4K | 219,647 | 0.0% |
| Allergan PLC | SHARES | G0177J108 | $38.6K | 142,009 | 0.0% |
| Portola Pharmaceuticals | COMMON | 737010108 | $46.4K | 1,088,118 | 0.0% |
| Seattle Genetics Inc | COMMON | 812578102 | $48.9K | 1,269,075 | 0.0% |
| Pfizer Inc(PFE) | COMMON | 717081103 | $53.7K | 1,711,016 | 0.0% |
| Merck & Co Inc(MRK) | COMMON | 58933Y105 | $54.2K | 1,097,376 | 0.0% |
| Thermo Fisher Scientific(TMO) | COMMON | 883556102 | $74.1K | 605,636 | 0.0% |
| Vertex Pharmaceuticals(VRTX) | COMMON | 92532F100 | $76.5K | 734,200 | 0.0% |
| Amgen Inc(AMGN) | COMMON | 031162100 | $76.7K | 554,697 | 0.0% |
| Amicus Therapeutics(FOLD) | COMMON | 03152W109 | $85.5K | 6,111,227 | 0.0% |
| Incyte Corporation(INCY) | COMMON | 45337C102 | $97.9K | 887,051 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COMMON | 015351109 | $112.9K | 721,593 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COMMON | 75886F107 | $113.5K | 244,100 | 0.0% |
| Celgene Corp(CELG) | COMMON | 151020104 | $137.1K | 1,267,158 | 0.0% |
| Gilead Sciences Inc(GILD) | COMMON | 375558103 | $182.3K | 1,856,458 | 0.1% |
| Coherus Biosciences(CHRS) | COMMON | 19249H103 | $331.0K | 16,498 | 0.1% |
| Amphastar Pharmaceuticals(AMPH) | COMMON | 03209R103 | $489.0K | 41,800 | 0.2% |
| Ascendis Pharma A S(ASND) | SP ADR | 04351P101 | $550.0K | 31,100 | 0.2% |
| Acadia Healthcare(ACHC) | COMMON | 00404A109 | $8.5M | 128,054 | 2.6% |
| Align Tech Inc(ALGN) | COMMON | 016255101 | $29.1M | 512,393 | 8.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COMMON | 09061G101 | $102.1M | 969,823 | 31.4% |
| Biogen Inc(BIIB) | COMMON | 09062X103 | $182.4M | 625,096 | 56.1% |